With over 20 years of clinical practice and pharmacometric experience, we know how to analyse trial data from the pharmaceutical and biotechnology industry.
Model Answers regularly attends conferences and visits clients worldwide. Please contact Bruce Green if you would like us to visit you.
With over 20 years of clinical practice and pharmacometric experience, we know how to analyse trial data from the pharmaceutical and biotechnology industry. Model Answers Pty Ltd uses innovative model based methodologies to help the industry make informative decisions during the entire drug development program and specialises in:
- Population Pharmacokinetic Analyses
- Population Pharmacokinetic – Pharmacodynamic Analyses
- Disease Progression Modelling
- Optimal Design of Clinical Trial
- Stochastic Simulation Studies
Article published in the AAPS Journal – Springer
The article explores the impact of model-misspecification on dose recommendations and clinical outcomes from personalised dosing.
Posted on July 20, 2016
Article Published in the Wiley Online Library
Julia’s postdoctoral work on a model-based meta analysis in COPD was recently published. Please read the paper here;
Posted on May 30, 2016
TMC125 Population PK model build poster presented at PAGE 2015
Download a copy of our TMC125 model build poster presented by Model Answers at PAGE in Crete.
Posted on July 14, 2015
R&D Tax Incentive
The Australian Government provides generous incentives for R&D work to be performed in Australia. You may be eligible for a 42.5% rebate on services performed by Model Answers. See the Australian Government website for more details.
Posted on October 23, 2014
- ~ Imaginot Pty Ltd
Imaginot’s relationship with Bruce Green extends back to 2004 when he undertook a consulting assignment to review the results of a proof of concept pharmacokinetic (PK) study and recommend what further analyses could be undertaken to translate the PK data into pharmacodynamic (PD) outcomes. That project was the basis for an ongoing collaboration with Bruce resulting in the results of the subsequent PK-PD modelling being submitted for publication.
- Read more testimonials »